Press Releases

DUBLIN, Ohio, Nov. 8, 2017 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that the board of directors approved a regular quarterly dividend of $0.4624 per share, payable Jan. 15, 2018, to shareholders of record on Jan. 2, 2018. 

In addition, the company released preliminary results of shareholder voting at its annual meeting of shareholders. Based on preliminary voting results, shareholders re-elected all 11 members to the board of directors, ratified Ernst & Young as the company's independent, registered public accounting firm, and, on an advisory basis, approved the compensation of the company's named executive officers and selected an annual vote on the frequency of future advisory votes to approve executive compensation. One shareholder proposal failed to pass. 

On Monday, Nov. 6, Cardinal Health announced that it named Mike Kaufmann, its current chief financial officer, to serve as the company's next chief executive officer and join the board of directors, effective Jan. 1, 2018. Kaufmann will succeed George Barrett, Cardinal Health's chairman and chief executive officer since 2009, who will continue to serve as executive chairman of the board of directors through the annual meeting of shareholders in November 2018. At that time, Gregory Kenny, Cardinal Health's lead independent director, will assume the role of non-executive chairman.

Results of the shareholder meeting will be posted on the company's Investor Relations page at http://ir.cardinalhealth.com in the coming days.

About Cardinal Health
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company provides clinically proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. Cardinal Health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. Because Cardinal Health helps ensure pharmacists and the consumers they serve have access to medications they need while working to help prevent prescription drug diversion, the company and its education partners created Generation Rx, a national program to help prevent the misuse of prescription medications. Backed by nearly 100 years of experience, with approximately 50,000 employees in nearly 60 countries, Cardinal Health ranks #15 on the Fortune 500. For more information, visit cardinalhealth.com, follow @CardinalHealth on Twitter and connect on LinkedIn at linkedin.com/ company/cardinal-health.

SOURCE Cardinal Health